Successful treatment of alopecia universalis with alefacept: A case report and review of the literature

Cutis

Volumn 81, Issue 5, 2008, Pages 431-434

  Bui, Kim ^a   Polisetty, Sudhir ^b   Gilchrist, Heidi ^a   Jackson, Scott M ^a   Frederic, Jeffrey ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; EFALIZUMAB; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; INFLIXIMAB; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; IMMUNOLOGY;

ADULT; ALOPECIA; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 44649158952     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Garcia Bartels N, Lee HH, Worm M, et al. Development of alopecia areata universalis in a patient receiving adalimumab. Arch Dermatol. 2006;142:1654-1655.
2. Heffernan MP, Hurley MY, Martin KS, et al. Alefacept for alopecia areata. Arch Dermatol. 2005;141:1513-1516.
3. Kaelin U, Hassan AS, Braathen LR, et al. Treatment of alopecia areata partim universalis with efalizumab. J Am Acad Dermatol. 2006;55:529-532.
4. Tosti A, Pazzaglia M, Starace M, et al. Alopecia areata during treatment with biologic agents. Arch Dermatol. 2006;142:1653-1654.
5. Strober BE, Siu K, Alexis AF, et al. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol. 2005;52: 1082-1084.
6. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol. 2005;141:759-760.
7. Ettefagh L, Nedorost S, Mirmirani P. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol. 2004;140:1012.
8. Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet. 1995;96:433-436.
9. Philpott MP, Sanders DA, Bowen J, et al. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol. 1996;135:942-948.